The funds will be used for expanding access to treatments for opioid
overdosing and to gather case data from across states, the HHS said.
The Centers for Disease Control and Prevention will spend $900
million over three years - about $301 million in the first year - to
help states and territories track overdose data as closely as
possible, the HHS said
https://www.hhs.gov/about/news/
2019/09/04/trump-administration-announces-1-8-billion-funding-states-combating-opioid.html
in a statement.
Meanwhile, HHS unit Substance Abuse and Mental Health Services
Administration is awarding about $932 million to support prevention,
treatment and recovery services.
Prescription opioid pain treatments and drugs like heroin and the
more potent fentanyl were responsible for 47,600 U.S. deaths in
2017, according to the government, with only a small decline last
year.
[to top of second column] |
Drugmakers such as Johnson & Johnson and Endo International Plc are
facing several lawsuits brought by states, counties and
municipalities that seek to hold the companies responsible for
opioid abuse nationwide.
A U.S. judge on Tuesday rejected efforts by major drugmakers,
pharmacies and distributors to dismiss claims that they caused the
nation's opioid crisis, clearing the way for a landmark trial even
as the judge pushes for a nationwide settlement.
(Reporting by Manas Mishra in Bengaluru; Editing by Shinjini Ganguli)
[© 2019 Thomson Reuters. All rights
reserved.] Copyright 2019 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |